Aberdeen Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Buy |
61,597
+9,728
| +19% | +$394K | ﹤0.01% | 764 |
|
|
2025
Q1 | $2.66M | Sell |
51,869
-41,781
| -45% | -$2.15M | 0.01% | 738 |
|
|
2024
Q4 | $5.19M | Sell |
93,650
-8,905
| -9% | -$493K | 0.01% | 644 |
|
|
2024
Q3 | $3.37M | Hold |
102,555
| – | – | 0.01% | 713 |
|
|
2024
Q2 | $2.79M | Buy |
102,555
+30,523
| +42% | +$830K | 0.01% | 718 |
|
|
2024
Q1 | $2.62M | Hold |
72,032
| – | – | 0.01% | 749 |
|
|
2023
Q4 | $1.46M | Buy |
+72,032
| New | +$1.46M | ﹤0.01% | 803 |
|